For more than half a century it has been generally believed that cancer cells are more acidic than normal cells. This dogma arose from the studies of Warburg and co-workers (Warburg, 1930) who showed that tumour cells preferentially convert glucose and other substrates to lactic acid, even under aerobic conditions. Since lactic acid has a pK of 3.7 it seemed obvious that the intracellular fluid would become acidic. Studies on cultured tumour cells or spheroids often showed low intracellular pH (pHi) values, but this could have been due to their highly artificial situation. What would be the pHi of cells in a solid tumour in a patient?
The development of pH electrodes small enough to be inserted into living tissues led to the apparent confirmation of the prevailing wisdom. Numerous studies (reviewed by WikeHooley et al., 1984 and Vaupel et al., 1989 ; see also Figure   lb ) showed significantly more acidic pH (pHpoT) in tumours than that in normal tissues. Microelectrodes that can be used on solid tumours in vivo are usually quite large in comparison to a tumour cell (see Wike-Hooley et al., 1984, Table II) , and they mainly measure the pH of the extracellular fluid (pHe) rather than pHi (Vaupel et al., 1989) . For most purposes, the parameter of interest is pH1, the pH of the water in the cancer cell itself, but it was generally expected (and then tacitly assumed) that pHi would also be acidic.
This supposed cellular acidity in tumours became part of the mental wallpaper of oncologists and cancer researchers, even though there was, for many years, no practical way to measure pHi of intact human tumours. It had clinical consequences, too, since anticancer treatments were often designed to take advantage of a low pH, (for a review, see WikeHooley et al., 1984) . It was argued, for instance, that anticancer drugs would be more effective if they contained ionising groups that would cause them to be trapped in acidic environments (Wike-Hooley et al., 1984) , or that radioresistant hypoxic cells would have a particularly low pHi and might therefore be especially sensitive to treatments such as hyperthermia which are known to act preferentially on isolated cells in acidic media (Freeman et al., 1981) . There were also numerous attempts to lower pHi still further by administration of glucose, and thereby enhance the action of various pH-sensitive therapies (Ross, 1961, reviewed by Wike-Hooley et al., 1984) . In general, these ideas have had little clinical success, but they are still the subject of active research (see, for instance, Tannock & Rotin, 1989 (Griffiths et al., 1981; Iles et al., 1982) and man (Griffiths et al., 1983 Magnetic Resonance Spectroscopy (MRS) have shown that human tumours were slightly more alkaline than the normal tissues from which they arose (Oberhaensli et al., 1986 , Vaupel et al., 1989 .
The results of a number of Magnetic Resonance Spectroscopy examinations of pHi in normal human tissues and in human tumours have been reviewed by Vaupel et al. (1989) and compared with similar data from microelectrode studies. (Arnold et al., 1990; Koutcher et al., 1990; Redmond et (Moon & Richards, 1973; Prichard et al., 1983) . Absolute pHi can be determined by MRS with a precision of 0.06pH (Smith et al., 1989) ; smaller relative changes are also reproducibly detectable. Errors can arise from partial volume effects (when some of the phosphocreatine signal, for instance, arises from adjacent muscle rather than the tumour itself (see Smith et al., 1989; Bhujwalla (1988) has demonstrated that tumour extracellular Pi concentration is not, in fact, abnormally high, and that the Pi concentration in the necrotic volumes of tumours is no higher than that in other extracellular fluids (approximately 2 mM). Stubbs and co-workers have recently extended and confirmed these studies (Stubbs et al., submitted for publication). Lastly, the ionic content of the medium in which the standard titration is performed must match that of the cell (Roberts & Jardetsky, 1981 (Griffiths et al., 1981) . The value of pHi determined from the DOG-6-P peak was much less than that determined from the Pi peak. In (Rottenberg et al., 1984 , Vaupel et al., 1989 . This also gives generally more alkaline results in brain tumours than in normal brain, tending to confirm the pHMRS data.
There is clearly a paradox here. The pHi of tumour cells (as measured by MRS) is close to neutrality, as is that of normal cells. The (predominately) extracellular pH measured in tumours by microelectrodes, on the other hand, tends to be acidic, sometimes substantially so. To resolve this paradox we must bear in mind that lactic acid is largely dissociated in vivo to H+ and lactate-. The cell has a number of mechanisms for exporting H+ ions, and a carrier-mediated system for exporting lactic acid (but not lactate-). To It should not, in fact, be surprising that tumour cells maintain their pHi near neutrality. Tumours may remain alive for periods of months or even years so it is obvious that in the long run their cells must export H+ at the same rate as they synthesise it -otherwise they would dissolve. Presumably they use the same H+ exporting systems as normal cells, and, as in normal cells, the homeostatic mechanism is set to give a near-neutral pHi. If the H+ exporting systems are significantly overloaded the tumour cell's passive buffering mechanisms will eventually be overcome and it will die. Otherwise pHi will stay near neutrality. The simplest explanation for the more alkaline pHi observed in some tumours would be a more active cellular proton extrusion.
Another paradox concerns the tumour lactate-concentration. Measurements of the lactate ion content of solid tumours in animals do indeed show that it is present at abnormally high concentrations (Griffiths et al., 1987) , yet the intracellular H+ content is, as we have seen, normal. However, this is also to be expected. Lactate ions are not extruded from tumour cells only the protonated form, i.e. lactic acid, crosses the cell membrane (Spencer & Lehninger, 1976) . The rate at which lactic acid is lost is proportional to the difference between the intracellular and extracellular pH (Masuda et al., 1990) ; if pHe becomes more acid while pH, remains the same, lactic acid extrusion will be reduced and lactate-ions will accumulate intracellularly
The relationship between tumour intracellular and extracellular pH is therefore opposite to the conventional wisdom. Instead of tumour cells being acidic they are neutral, or slightly alkaline. It is the pH of the extracellular fluid, as determined by microelectrodes that is acidic. Thus, if one designs a drug with a low pK, intending it to partition preferentially into acidic tumour cells, it is more likely to partition preferentially into the tumour extracellular fluid, where it will probably be useless, unless it interacts with the cell membrane.
All these results are concerned with unperturbed tumours.
In the short term, it is certainly possible to lower the pHi of animal tumours by a number of manoeuvres as can be demonstrated by MRS. Glucose administration can cause acidification (Evelhoch et al., 1984) as can drugs such as hydralazine, that accentuate anaerobic metabolism by lowering tumour blood flow (Tozer et al., 1990) . In another study by combined 31P and 'H MRS it was possible to induce acidification and lactate formation in the rat SG prolactinoma by stimulating the secretion of prolactin (Maxwell et al., 1988) . When the buffering power of tumour homogenates was allowed for, the fall in pHi was exactly equivalent to the rise in H+.
Strategies aimed at lowering pHi in human tumours by enhancing lactic acid synthesis may still be successful, therefore, but only in the short term. This, of course, could be sufficient, if the acidification is coordinated with a treatment modality (radiotherapy, hyperthermia, etc.) that also acts in the short term. Our ability to measure tumour pHi noninvasively and repeatedly by MRS could make such strategies practicable, as the behaviour of the individual tumour could be followed.
There is a more important general point. For the past half century, one of the few things we thought we knew about tumour metabolism was the opposite of the truth. Now that the correct state of affairs is evident we may be able to target the real abnormalities (enhanced H+ extrusion and lactate retention) rather than the illusory acidic tumour cell.
